Project Grant R15DK139519
Award Date
9/15/24
Completion Date
8/31/27
Dollars Obligated
$319K
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $494,696 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The University of Texas Health Science Center at San Antonio (UTHSCSA). The grant will fund research to better understand the translational control mechanisms that allow the fungal pathogen Candida albicans to respond to host environmental stresses and undergo critical morphological changes that enable infection....
This federal Project Grant award of $146,922 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research on the role of gut protist-derived compounds in modulating dietary antigen presenting dendritic cells in celiac disease. The University of Pittsburgh will conduct this research project, which aims to gain insights into how the gut protist Tritrichomonas...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $152,216 to the University of Pittsburgh to conduct research on anti-fungal immune responses in the female reproductive tract. The research aims to determine the cellular and molecular basis for how type 3 cytokine signaling orchestrates immune control of vulvovaginal candidiasis (VVC), a prevalent and...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $284,184 to Duke University to investigate the role of the CuZnSOD1 protein in sensing copper-deficient conditions in the fungus Candida albicans. The research aims to further elucidate the mechanisms by which C. albicans, a common human pathogen, adapts its copper homeostasis pathways in response to copper-deficient...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $265,650 over a 2-year period from February 1, 2025 to January 31, 2027 to HMH Hospitals Corporation (dba Hackensack University Medical Center) to conduct research on the evolutionary dynamics of the fungal pathogen Candida glabrata in the gastrointestinal tract. The study aims to elucidate how antifungal drug treatment and immune dysfunction...
This $233,670 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to determine the genetic mechanisms underlying skin colonization by the emerging fungal pathogen Candida auris. The University of Michigan, the awardee, will leverage its established in vitro and in vivo models to investigate clade-specific differences in C. auris adhesion and skin...
This $500,902 National Science Foundation project grant supports research into polyamine regulated morphogenesis in the fungal pathogen Candida albicans at Texas A&M International University from August 15, 2022 to July 31, 2025. The grant falls under the NSF Biological Sciences program (CFDA 47.074), which aims to increase scientific knowledge and understanding of major biological problems. The university will investigate the molecular mechanisms by which polyamines regulate fungal growth...
The National Institute of General Medical Sciences (NIGMS) awarded a $415,520 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the College of William & Mary. This 3-year grant supports research to investigate the genetic basis of virulence traits in opportunistic fungal pathogens and how these traits may arise through "accidental virulence" or "coincidental selection" in the environment. The research will screen over 1,000...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $857,215 to HMH Hospitals Corporation (doing business as Hackensack University Medical Center) to conduct research on how the fungal pathogen Candida albicans adapts to different host environments, such as the oral and systemic infection niches. The research aims to decipher how the fungal acetylome, regulated by the...
This $134,800 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research by Dr. Shakti Singh at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The project aims to: Study the role of Hyr1/Iff-like (CAU-HIL) proteins in the virulence of the multidrug-resistant pathogen Candida auris, which causes life-threatening bloodstream infections....